Rhabdomyolysis as a dangerous complication of primary hyperaldosteronism
- 20 November 2025
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 16,p. 273-282
Abstract
Rhabdomyolysis is a rare, dangerous complication of primary hyperaldosteronism (PHA) induced by hypokalemia. PHA is underdiagnosed because it does not have a specific, easily identifiable feature and clinicians can be poorly aware of the disease. Prompt diagnosis of PHA and the use of targeted treatment strategies mitigate aldosterone-specific target organ damage, such as rhabdomyolysis. Progressive muscle weakness, as the main symptom of the development of muscle damage, is a reason to monitor electrolyte balance. We present a detailed description of two cases of rhabdomyolysis with hypokalemia. Patient 1, 45 y.o., with an increase in blood pressure (BP) to 220/120 mmHg, which could not be corrected against the background of 3-component antihypertensive therapy, with complaints of headaches, dizziness, sweating, severe muscle weakness of the extremities, muscle pain, was acutely admitted to the hospital, where creatine phosphokinase (CPK) 17204 IU/l (up to 145), CPKMB 205 IU/L (up to 24), AST 889 U/L (up to 35), ALT 232 U/L (up to 40), blood potassium 2.0 mmol/L (3.3–5.5). Neurologist, rheumatologist excluded pathology. Aldosteroma of the right adrenal gland was detected with normalization of BP and potassium levels after adrenalectomy. Patient 2, 55 y.o., with an increased BP of 200/110 mmHg, general and muscular weakness, severe pain in the muscles and joints of the extremities, shortness of breath during physical exertion, heart arrhythmia, was observed for 6 years by a cardiologist, neurologist, rheumatologist, with repeated hospitalizations, including for about rhabdomyolysis. Despite recurrent hypokalemia, the adrenal gland examination was performed only after consultation with an endocrinologist due to loss of consciousness in case of hypoglycemia. The examination revealed primary hyperparathyroidism, bilateral PHA, non-toxic nodular goiter, pituitary microadenoma. Hypoglycemia was not achieved in the 72-hour fasting trial. Multiple endocrine neoplasia type 1 syndrome has been established clinically. In the available literature in Russian and in English, we have found the description of less than 40 similar case reports. A detailed description of those cases is also provided.Keywords
This publication has 23 references indexed in Scilit:
- Primary Aldosteronism: A Pragmatic Approach to Diagnosis and ManagementMayo Clinic Proceedings, 2023
- Approach to the Patient on Antihypertensive Therapy: Screen for Primary AldosteronismThe Journal of Clinical Endocrinology & Metabolism, 2022
- How common is primary aldosteronism?Current Opinion in Nephrology and Hypertension, 2021
- Primary AldosteronismJACC, 2019
- Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective StudyThe Journal of Clinical Endocrinology & Metabolism, 2019
- Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysisThe Lancet Diabetes & Endocrinology, 2018
- The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2016
- Hypokalemia-Induced Rhabdomyolysis as a result of Distal Renal Tubular Acidosis in a Pregnant Woman: A Case Report and Literature ReviewCase Reports in Obstetrics and Gynecology, 2015
- Rhabdomyolysis due to primary hyperaldosteronismEndocrinología y Nutrición, 2009
- Hypertension Associated With Rhabdomyolysis May Also Be Caused by Unilateral Adrenal HyperplasiaThe Journal of Clinical Hypertension, 2009